Yunnan Jianzhijia Health-Chain Co., Ltd.
SSE:605266.SS
22.2 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9,282.846 | 9,080.697 | 7,514.444 | 5,234.955 | 4,466.357 | 3,528.526 | 2,765.851 | 2,346.875 | 2,053.84 | 1,844.317 | 1,667.138 |
| Cost of Revenue
| 5,959.508 | 5,844.588 | 4,798.911 | 3,359.113 | 2,961.494 | 2,288.284 | 1,720.917 | 1,475.372 | 1,268.757 | 1,151.781 | 1,046.629 |
| Gross Profit
| 3,323.338 | 3,236.109 | 2,715.534 | 1,875.843 | 1,504.864 | 1,240.242 | 1,044.934 | 871.503 | 785.083 | 692.536 | 620.509 |
| Gross Profit Ratio
| 0.358 | 0.356 | 0.361 | 0.358 | 0.337 | 0.351 | 0.378 | 0.371 | 0.382 | 0.375 | 0.372 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 83.129 | 51.63 | 70.68 | 53.146 | 42.946 | 35.043 | 23.14 | 37.408 | 64.616 | 57.431 | 46.266 |
| Selling & Marketing Expenses
| 1,364.316 | 1,168.001 | 1,910.767 | 1,339.644 | 1,040.494 | 888.402 | 751.936 | 628.524 | 605.315 | 576.253 | 515.918 |
| SG&A
| 1,447.445 | 1,219.631 | 1,981.447 | 1,392.789 | 1,083.44 | 923.445 | 775.075 | 665.932 | 669.931 | 633.683 | 562.184 |
| Other Expenses
| 1,699.815 | 1,516.209 | 148.105 | 72.234 | 105.113 | 71.694 | 1.338 | 1.163 | 1.381 | 2.375 | 4.525 |
| Operating Expenses
| 3,147.26 | 2,735.84 | 2,129.552 | 1,465.024 | 1,188.553 | 995.139 | 847.698 | 727.145 | 683.067 | 651.113 | 578.349 |
| Operating Income
| 176.078 | 639.62 | 445.384 | 353.787 | 292.306 | 221.32 | 178.774 | 128.187 | 86.968 | 25.644 | 22.689 |
| Operating Income Ratio
| 0.019 | 0.07 | 0.059 | 0.068 | 0.065 | 0.063 | 0.065 | 0.055 | 0.042 | 0.014 | 0.014 |
| Total Other Income Expenses Net
| -7.131 | -116.925 | -105.908 | -28.554 | 8.195 | 0.427 | -4.443 | 1.163 | -6.164 | -7.842 | -11.795 |
| Income Before Tax
| 168.947 | 522.695 | 440.738 | 358.228 | 300.502 | 218.416 | 180.112 | 129.35 | 88.349 | 27.872 | 26.5 |
| Income Before Tax Ratio
| 0.018 | 0.058 | 0.059 | 0.068 | 0.067 | 0.062 | 0.065 | 0.055 | 0.043 | 0.015 | 0.016 |
| Income Tax Expense
| 40.989 | 108.21 | 77.347 | 58.973 | 51.093 | 52.149 | 47.438 | 35.79 | 19.407 | 11.179 | 10.87 |
| Net Income
| 128.126 | 414.412 | 374.294 | 300.527 | 251.148 | 168.115 | 133.604 | 94.732 | 70.885 | 17.972 | 17.35 |
| Net Income Ratio
| 0.014 | 0.046 | 0.05 | 0.057 | 0.056 | 0.048 | 0.048 | 0.04 | 0.035 | 0.01 | 0.01 |
| EPS
| 0.83 | 2.69 | 2.9 | 2.58 | 2.16 | 1.44 | 1.53 | 1.08 | 0.81 | 0.2 | 0.2 |
| EPS Diluted
| 0.83 | 2.68 | 2.9 | 2.58 | 2.16 | 1.44 | 1.53 | 1.08 | 0.81 | 0.2 | 0.2 |
| EBITDA
| 1,132.972 | 1,392.579 | 1,263.799 | 961.481 | 330.324 | 259.52 | 209.969 | 185.025 | 143.893 | 51.817 | 48.832 |
| EBITDA Ratio
| 0.122 | 0.153 | 0.168 | 0.184 | 0.074 | 0.074 | 0.076 | 0.079 | 0.07 | 0.028 | 0.029 |